Company Horizon Therapeutics Public Limited Company
Equities
HZNP
IE00BQPVQZ61
Pharmaceuticals
Business Summary
Number of employees: 2,190
Managers
Managers | Title | Age | Since |
---|---|---|---|
Karin Rosen
CTO | Chief Tech/Sci/R&D Officer | 57 | 20-11-01 |
Chief Tech/Sci/R&D Officer | 66 | 16-09-30 | |
Jeffrey Sherman
CTO | Chief Tech/Sci/R&D Officer | 69 | 09-05-31 |
Comptroller/Controller/Auditor | 45 | 15-01-31 | |
David Caraher
SEC | Corporate Secretary | - | - |
Jane Gonnerman
HRO | Human Resources Officer | - | 21-09-30 |
Sean Clayton
LAW | General Counsel | 45 | 22-02-22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 229,378,934 | 226,691,767 ( 98.83 %) | 384,366 ( 0.1676 %) | 98.83 % |
Company contact information
Horizon Therapeutics Plc
70 St. Stephen's Green Saint Kevin's
2, Dublin
+353 1 772 2100
http://www.horizontherapeutics.comGroup companies
Name | Category and Sector |
---|---|
Horizon Pharma Treasury Ltd.
|
Sector
1st Jan change | Capi. | |
---|---|---|
+42.60% | 748B | |
+32.34% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+16.47% | 245B | |
+9.26% | 211B | |
-5.07% | 209B | |
+6.74% | 165B |